{{Rsnum
|rsid=1133763
|Gene=CCL8
|Chromosome=17
|position=34320812
|Orientation=plus
|ReferenceAllele=A
|MissenseAllele=C
|GMAF=0.1956
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=CCL8
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 76.4 | 20.9 | 2.7
| HCB | 55.6 | 40.0 | 4.4
| JPT | 51.1 | 44.4 | 4.4
| YRI | 94.5 | 5.5 | 0.0
| ASW | 72.7 | 27.3 | 0.0
| CHB | 55.6 | 40.0 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 24.0 | 60.4 | 15.6
| LWK | 76.1 | 22.9 | 0.9
| MEX | 51.7 | 44.8 | 3.4
| MKK | 71.4 | 26.0 | 2.6
| TSI | 77.2 | 21.8 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19415413
|Title=CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration
}}

{{PMID|17848170|OA=1
}} The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

{{GET Evidence
|gene=CCL8
|aa_change=Lys69Gln
|aa_change_short=K69Q
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1133763
|overall_frequency_n=1412
|overall_frequency_d=10758
|overall_frequency=0.131251
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.963
|nblosum100=-2
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}